Portfolio News

Data Mining will Become Essential to Reduce the Disease Burden and Empower Healthcare Stakeholders

An increasing number of people, from patients to payers to biotech companies to providers, are playing a role in medical decision-making, and pharmaceutical companies are looking for more effective ways to communicate the value of innovative treatments they offer. One of the ways they are doing so is by looking to evidence-based programs that provide opportunities for action to convince these stakeholders of a treatment’s value. A comprehensive data set can help analytics teams see millions of patient journeys and quickly identify patients and providers...

Rehumanizing Doctor-Patient Relationships with Manny Krakaris, CEO, Augmedix

In a recent episode of the Cowen Insights podcast, Cowen’s healthcare technology analyst, Charles Rhyee, spoke with Augmedix CEO Manny Krakaris. They discussed the administrative burden of medical note documentation on providers today and how Augmedix’s offerings can increase productivity and prevent physician burnout. Augmedix provides a remote scribe service that leverages technology such as AI, machine learning, and natural language processing to save clinicians an estimated 2-3 hours a day. The remote sessions are transcribed into notes that go into a patient’s chart, along with...

Covid and Big Tech are pushing Augmented Reality into modern healthcare

There is an Augmented Reality revolution happening in healthcare. You can see it at places like Alder Hey Children’s Hospital in Liverpool, England, where a pediatric heart surgeon recently used a pair of Microsoft HoloLens 2 smart glasses to transmit the view of the patient’s heart live to distant colleagues, as well as reviewing the patient’s echocardiogram at the same time. The HoloLens 2 device running Microsoft’s remote assist software Dynamics 365 allowed the same surgeon to perform his rounds alone, minimizing the risk of both...

Drive to end cancer could pioneer diagnostic technology

GRAIL, the developer of multi-cancer early detection test Galleri, is building on its earlier commercial partnership with the UK’s National Health Service. That partnership aims to confirm Galleri’s clinical and economic performance in the UK healthcare system, which is one step toward regular use by the NHS. GRAIL recently presented its first results for PATHFINDER, an interventional study evaluating Galleri, specifically studying people ages 50 and older because of their increased risk of cancer. None of the study participants had suspicion of active cancer when the...

Will digital health funding boom or bust? 5 experts weigh in

Rock Health CEO Bill Evans was one of five experts interviewed by Health Evolution about whether or not investment in the digital health sector will continue at its current pace over the years to come. In addition to asking about the pace of investment, the experts were asked about the role special purpose acquisition companies (SPACs) played in the current funding surge. In response to the question of whether the digital health funding boom is a bubble or something more sustainable, Evans was optimistic. “Healthcare is...